The State of Weight-Loss Drugs

The State of Weight-Loss Drugs

$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big-name prescriptions differ from each other. - What investors need to know about Ozempic and Mounjarno’s patent cliffs. - The scenarios in which Novo Nordisk and Eli Lilly are actually undervalued. Companies discussed: LLY, NOVO, HIMS, PFE, RHHBY, VKTX, GPCR, ISRG Host: Ricky Mulvey Guest: Karl Thiel Producer: Mary Long Engineer: Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(2382)

Marvell’s Trillion-Dollar Target

Marvell’s Trillion-Dollar Target

Custom silicon company Marvell wants to acquire Lumentum at $115 billion, dwarfing many previous deals in the publicly-traded tech space. Jon, Matt, and Rachel talk about why Marvell is so eager to br...

2 Nov 25min

Three Questions Every Investor Should Ask About Any Management Team Video Draft 28m 45s

Three Questions Every Investor Should Ask About Any Management Team Video Draft 28m 45s

A record number of CEOs have departed for two years running — and it's not because they lacked intelligence or experience. It's because the map they were using became outdated overnight. Motley Fool...

1 Nov 30min

Financial Horror Stories, Vol. 5: The All-Monster Edition

Financial Horror Stories, Vol. 5: The All-Monster Edition

The witching hour approaches! For the fifth consecutive year, Motley Fool financial planning expert Robert Brokamp joined Motley Fool co-founder David Gardner on his Rule Breaker Investing podcast to ...

31 Okt 56min

Is Wall Street Turning on AI?

Is Wall Street Turning on AI?

Alphabet’s sharp sell-off raises a big question: Are investors more concerned about AI spending than AI growth? The team breaks down Anthropic’s IPO filing, the risks of massive AI infrastructure comm...

30 Okt 40min

Alphabet Almost Sets a Record No One Wants

Alphabet Almost Sets a Record No One Wants

Alphabet lost a staggering amount of market cap today, reflecting investors’ negativity regarding its incredible spending on AI infrastructure. By contrast, Microsoft’s quarterly report was better rec...

29 Okt 24min

Is Robinhood Stock Too Expensive?

Is Robinhood Stock Too Expensive?

Robinhood's growth is slowing, but new products and subscription revenue could offer a path forward. Oracle is diversifying beyond Nvidia as competition in AI chips heats up. Meanwhile, Microsoft's la...

28 Okt 18min

SoFi’s Earnings Shine While PayPal & Boeing’s Earnings Look “Meh”

SoFi’s Earnings Shine While PayPal & Boeing’s Earnings Look “Meh”

When a bank’s earnings cause the stock to pop more than 15%, then something definitely went right. At least that is what appears to have happened at SoFi this most recent quarter thanks to an earnings...

27 Okt 23min

Anthropic’s $500 Billion Question

Anthropic’s $500 Billion Question

Anthropic's highly anticipated IPO filing reveals explosive growth, surprisingly strong financials, and nearly $500 billion in future AI computing commitments. Meanwhile, Meta looks to raise $95 billi...

26 Okt 19min

Populärt inom Business & ekonomi

framgangspodden
rss-hemlispodden
varvet
rss-jossan-nina
bathina-en-podcast
rss-borsens-finest
rss-svart-marknad
uppgang-och-fall
rss-hos-psykologen
badfluence
rss-inga-dumma-fragor-om-pengar
rss-dr-bjorklund
avanzapodden
24fragor
fill-or-kill
lastbilspodden
bilar-med-sladd
tabberaset
rss-kort-lang-analyspodden-fran-di
kapitalet-en-podd-om-ekonomi